ALCL Clinical Trial
Official title:
Study of the Biological Mechanisms Associated With the Immunogenicity in Anaplastic Large Cell Lymphoma ( ALCL ) ALK +
To study the correlation between the polymorphism of the main immunity genes and progression-free survival in ALCL of the child.
n/a
Status | Clinical Trial | Phase | |
---|---|---|---|
Withdrawn |
NCT04021082 -
CELTIC-1: A Phase 2B Study of Cerdulatinib in Patients With Relapsed/Refractory Peripheral T-Cell Lymphoma (PTCL)
|
Phase 2/Phase 3 | |
Recruiting |
NCT05160922 -
Crizotinib Continuation Clinical Study
|
Phase 4 |